Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer

• Status: Unknown status
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Pilot study of Zoledronic acid in combination with first-line chemotherapy in aged patients with lung cancer. The purpose is to assess the effects of Zoledronic acid in combination with first-line chemotherapy in aged patients with lung cancer on bone mineral density gain in the lumbar spine and total hip.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hebei Tumor Hospital
• Treatments: Diphosphonates; Zoledronic Acid

Criteria

Inclusion Criteria:

• Signed informed consent form

• Age ≥70 years

• Performance Status- Eastern Cooperative Oncology Group (ECOG) 0-1

• Histologically or cytologically confirmed lung cancer

• Did not receive bisphosphonate treatment

Exclusion Criteria:

• Appear relapse and metastasis

• receive other bisphosphonate treatment

• Active or uncontrolled infection

• Pregnant or lactating women